Detalhe da pesquisa
1.
The impact of myasthenia gravis severity on work and daily activities.
Muscle Nerve
; 69(4): 428-439, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38348518
2.
Association of a risk allele of ANK3 with cognitive performance and cortical thickness in patients with first-episode psychosis.
J Psychiatry Neurosci
; 39(1): 31-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24016415
3.
Economic burden of generalized myasthenia gravis (MG) in the United States and the impact of common comorbidities and acute MG-events.
Curr Med Res Opin
; : 1-9, 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38745448
4.
Patient perceptions of disease burden and treatment of myasthenia gravis based on sentiment analysis of digital conversations.
Sci Rep
; 14(1): 7271, 2024 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38538905
5.
A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis.
Allergy Asthma Clin Immunol
; 19(1): 48, 2023 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248521
6.
LPHN3 and attention-deficit/hyperactivity disorder: interaction with maternal stress during pregnancy.
J Child Psychol Psychiatry
; 53(8): 892-902, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22486528
7.
Differential association between the norepinephrine transporter gene and ADHD: role of sex and subtype.
J Psychiatry Neurosci
; 37(2): 129-37, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22297068
8.
Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 years.
Mult Scler Relat Disord
; 49: 102717, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33476880
9.
Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223.
J Neurol
; 267(11): 3343-3353, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32583052
10.
Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study.
CNS Drugs
; 34(9): 973-988, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32710396
11.
Impact of genetic polymorphisms on opioid misuse: a scoping review.
Pharmacogenomics
; 20(9): 685-703, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31250732
12.
Placebo response and its determinants in children with ADHD across multiple observers and settings: A randomized clinical trial.
Int J Methods Psychiatr Res
; 27(1)2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28664541
13.
Catechol-o-methyltransferase gene and executive function in children with ADHD.
J Atten Disord
; 18(3): 202-11, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22451510
14.
TCF4 gene polymorphism and cognitive performance in patients with first episode psychosis.
Schizophr Res
; 152(1): 124-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24275585
15.
The mechanism of degeneration of striatal neuronal subtypes in Huntington disease.
Ann Neurosci
; 21(3): 112-4, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25206077
16.
Sonic hedgehog signalling pathway: a complex network.
Ann Neurosci
; 21(1): 28-31, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25206052
17.
Genetic evidence for the association of the hypothalamic-pituitary-adrenal (HPA) axis with ADHD and methylphenidate treatment response.
Neuromolecular Med
; 15(1): 122-32, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23055001
18.
Spatially regulated adult neurogenesis.
Ann Neurosci
; 20(2): 67-70, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25206016
19.
Body weight and ADHD: examining the role of self-regulation.
PLoS One
; 8(1): e55351, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23383165
20.
Association between obesity-related gene FTO and ADHD.
Obesity (Silver Spring)
; 21(12): E738-44, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23512716